Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 2Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 2Thrombocythemia, Essential 1Recurrence 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hematologic Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Basal Cell Nevus Syndrome 1

Interventions

fludarabine phosphate 22Cyclophosphamide 22Peripheral Blood Stem Cell Transplantation 21Tacrolimus 15Busulfan 14Cyclosporine 13Whole-Body Irradiation 12Mycophenolic Acid 12Methotrexate 12Antilymphocyte Serum 10Filgrastim 7Etoposide 6Radiotherapy 5Methylprednisolone 5Decitabine 5Carboplatin 5ruxolitinib 4fludarabine 4Melphalan 4Flow Cytometry 4Topotecan 3Thiotepa 3Cytogenetic Analysis 3Cytarabine 3veliparib 2merphos 2liposomal amphotericin B 2aldesleukin 2Watchful Waiting 2Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocythemia, Essential × sonidegib × Other hematologic neoplasm × Clear all
NCT02129101 2019-10-30

Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies

Mayo Clinic

Phase 1 Completed
63 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡